ADP-Ribosylation Factor GTPase Activating Protein 2 (ARFGAP2) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
ARFGAP2 Antibody is a Rabbit Polyclonal against ARFGAP2.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | ADP-Ribosylation Factor GTPase Activating Protein 2 (ARFGAP2) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purity | ≥ 95% (SDS-PAGE) |
| Purification | Purified by immunogen affinity chromatography. |
| Size 1 | 100 µg |
| Form | Liquid |
| Tested Applications | ELISA, WB |
| Buffer | PBS, pH 7.3, with 0.02% sodium azide and 50% glycerol. |
| Availability | Shipped within 5-12 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q8N6H7 |
| Gene ID | 84364 |
| OMIM | 606908 |
| Background | Antibody anti-ARFGAP2 |
| Status | RUO |
| Note | Concentration: 2 mg/ml - Validity: 12 months. |
Descripción
Related Products
ARFGAP2 antibody
GTPase-activating protein(GAP) for ADP ribosylation factor 1(ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes.
Ver Producto
ADP-Ribosylation Factor GTPase Activating Protein 2 (ARFGAP2) Antibody
GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes.
Ver Producto
ADP-Ribosylation Factor GTPase Activating Protein 2 (ARFGAP2) Antibody
ARFGAP2 Antibody is a Rabbit Polyclonal against ARFGAP2.
Ver Producto